PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=513230, encodeId=4fa5513230d8, content=我的奇葩经历，投cell，没有被送审被拒了。投mol cell，悲剧，还是没送审被拒绝。好吧，投cell res，毕竟是国人期刊，结果你猜啥，天哪，拖了2个月没反应。我真要爆粗口了，于是我果断撤回稿子，怀着忐忑的心情最后试试pnas（再不行就想放弃干脆jbc得了）。意料之外，半月后直接接受，只要改一改格式，真是汗啊。我的经历告诉我，现在的科学，就是金钱和利益和人脉，真正的学术早就不存在了，以后绝对不走科研道路！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.168.51.50, createdTime=Sun Jul 05 15:08:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物 经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学 经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学 经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202623, encodeId=958a12026237d, content=unde r editorial board review 好久了，还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff06473404, createdName=ms7000002025378955, createdTime=Mon Mar 14 23:17:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186804, encodeId=12691186804fc, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：发育生物学 经验分享：Stage Start Date Revision Started 2022-01-20 Waiting for Revision 2021-11-23 Review Complete; E-Mail Notification Sent 2021-11-23 Pending Recommendation 2021-11-16 Under Review 2021-10-26 Under Editor Review 2021-10-25 Under Editorial Board Review 2021-10-21 Quality Control Review Completed 2021-10-21 Quality Control Review Started 2021-10-18 Author Approved Submission 2021-10-18 Preliminary Manuscript Information Submitted 2021-10-18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bb75649951, createdName=ms4000000844349355, createdTime=Fri Jan 21 13:12:55 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841897, encodeId=562184189e40, content=pnas审稿很有意思，先要经过editor board，之后board选择editor，这editor可以是院士，也可以是非院士（guest editor），board和editor都可能拒稿。我的这两个过程耗费时间挺长，比较特殊，原因是editor对文章进行了初步审稿，并提出了详细修改意见和建议。根据意见补充数据修改提交后，editor找了2个审稿人，1个月左右给回复，对创新性、普遍性、数据量、写作等方面给出yes或者no，并提出了具体的意见。补数据修改提交后接收。共耗时8个月。总体感觉：editor水平很高，非常nice，从文章立题到创新性及补充实验等方面提出了很好的建议，极大改进了文章，受益匪浅。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Fri Mar 30 11:35:21 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003853, encodeId=d8131003853df, content=紧张，PNAS效率非常高，官网说送给Reviewers后10天内要求提交报告，因此如果Reviewers不拒审的话，一审时间非常快！ Stage Start Date Pending Recommendation 2021-07-29 Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Fri Jul 30 13:19:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

2015-07-05 60.168.51.50

我的奇葩经历，投cell，没有被送审被拒了。投mol cell，悲剧，还是没送审被拒绝。好吧，投cell res，毕竟是国人期刊，结果你猜啥，天哪，拖了2个月没反应。我真要爆粗口了，于是我果断撤回稿子，怀着忐忑的心情最后试试pnas（再不行就想放弃干脆jbc得了）。意料之外，半月后直接接受，只要改一改格式，真是汗啊。我的经历告诉我，现在的科学，就是金钱和利益和人脉，真正的学术早就不存在了，以后绝对不走科研道路！！

1198 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=513230, encodeId=4fa5513230d8, content=我的奇葩经历，投cell，没有被送审被拒了。投mol cell，悲剧，还是没送审被拒绝。好吧，投cell res，毕竟是国人期刊，结果你猜啥，天哪，拖了2个月没反应。我真要爆粗口了，于是我果断撤回稿子，怀着忐忑的心情最后试试pnas（再不行就想放弃干脆jbc得了）。意料之外，半月后直接接受，只要改一改格式，真是汗啊。我的经历告诉我，现在的科学，就是金钱和利益和人脉，真正的学术早就不存在了，以后绝对不走科研道路！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.168.51.50, createdTime=Sun Jul 05 15:08:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物 经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学 经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学 经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202623, encodeId=958a12026237d, content=unde r editorial board review 好久了，还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff06473404, createdName=ms7000002025378955, createdTime=Mon Mar 14 23:17:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186804, encodeId=12691186804fc, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：发育生物学 经验分享：Stage Start Date Revision Started 2022-01-20 Waiting for Revision 2021-11-23 Review Complete; E-Mail Notification Sent 2021-11-23 Pending Recommendation 2021-11-16 Under Review 2021-10-26 Under Editor Review 2021-10-25 Under Editorial Board Review 2021-10-21 Quality Control Review Completed 2021-10-21 Quality Control Review Started 2021-10-18 Author Approved Submission 2021-10-18 Preliminary Manuscript Information Submitted 2021-10-18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bb75649951, createdName=ms4000000844349355, createdTime=Fri Jan 21 13:12:55 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841897, encodeId=562184189e40, content=pnas审稿很有意思，先要经过editor board，之后board选择editor，这editor可以是院士，也可以是非院士（guest editor），board和editor都可能拒稿。我的这两个过程耗费时间挺长，比较特殊，原因是editor对文章进行了初步审稿，并提出了详细修改意见和建议。根据意见补充数据修改提交后，editor找了2个审稿人，1个月左右给回复，对创新性、普遍性、数据量、写作等方面给出yes或者no，并提出了具体的意见。补数据修改提交后接收。共耗时8个月。总体感觉：editor水平很高，非常nice，从文章立题到创新性及补充实验等方面提出了很好的建议，极大改进了文章，受益匪浅。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Fri Mar 30 11:35:21 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003853, encodeId=d8131003853df, content=紧张，PNAS效率非常高，官网说送给Reviewers后10天内要求提交报告，因此如果Reviewers不拒审的话，一审时间非常快！ Stage Start Date Pending Recommendation 2021-07-29 Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Fri Jul 30 13:19:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

2022-06-09 osmataku

收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions...

237 0

[GetPortalCommentsPageByObjectIdResponse(id=513230, encodeId=4fa5513230d8, content=我的奇葩经历，投cell，没有被送审被拒了。投mol cell，悲剧，还是没送审被拒绝。好吧，投cell res，毕竟是国人期刊，结果你猜啥，天哪，拖了2个月没反应。我真要爆粗口了，于是我果断撤回稿子，怀着忐忑的心情最后试试pnas（再不行就想放弃干脆jbc得了）。意料之外，半月后直接接受，只要改一改格式，真是汗啊。我的经历告诉我，现在的科学，就是金钱和利益和人脉，真正的学术早就不存在了，以后绝对不走科研道路！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.168.51.50, createdTime=Sun Jul 05 15:08:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物 经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学 经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学 经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202623, encodeId=958a12026237d, content=unde r editorial board review 好久了，还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff06473404, createdName=ms7000002025378955, createdTime=Mon Mar 14 23:17:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186804, encodeId=12691186804fc, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：发育生物学 经验分享：Stage Start Date Revision Started 2022-01-20 Waiting for Revision 2021-11-23 Review Complete; E-Mail Notification Sent 2021-11-23 Pending Recommendation 2021-11-16 Under Review 2021-10-26 Under Editor Review 2021-10-25 Under Editorial Board Review 2021-10-21 Quality Control Review Completed 2021-10-21 Quality Control Review Started 2021-10-18 Author Approved Submission 2021-10-18 Preliminary Manuscript Information Submitted 2021-10-18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bb75649951, createdName=ms4000000844349355, createdTime=Fri Jan 21 13:12:55 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841897, encodeId=562184189e40, content=pnas审稿很有意思，先要经过editor board，之后board选择editor，这editor可以是院士，也可以是非院士（guest editor），board和editor都可能拒稿。我的这两个过程耗费时间挺长，比较特殊，原因是editor对文章进行了初步审稿，并提出了详细修改意见和建议。根据意见补充数据修改提交后，editor找了2个审稿人，1个月左右给回复，对创新性、普遍性、数据量、写作等方面给出yes或者no，并提出了具体的意见。补数据修改提交后接收。共耗时8个月。总体感觉：editor水平很高，非常nice，从文章立题到创新性及补充实验等方面提出了很好的建议，极大改进了文章，受益匪浅。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Fri Mar 30 11:35:21 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003853, encodeId=d8131003853df, content=紧张，PNAS效率非常高，官网说送给Reviewers后10天内要求提交报告，因此如果Reviewers不拒审的话，一审时间非常快！ Stage Start Date Pending Recommendation 2021-07-29 Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Fri Jul 30 13:19:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

2022-05-10 ms1000000471957018

偏重的研究方向：微生物
经验分享：iii

205 0

[GetPortalCommentsPageByObjectIdResponse(id=513230, encodeId=4fa5513230d8, content=我的奇葩经历，投cell，没有被送审被拒了。投mol cell，悲剧，还是没送审被拒绝。好吧，投cell res，毕竟是国人期刊，结果你猜啥，天哪，拖了2个月没反应。我真要爆粗口了，于是我果断撤回稿子，怀着忐忑的心情最后试试pnas（再不行就想放弃干脆jbc得了）。意料之外，半月后直接接受，只要改一改格式，真是汗啊。我的经历告诉我，现在的科学，就是金钱和利益和人脉，真正的学术早就不存在了，以后绝对不走科研道路！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.168.51.50, createdTime=Sun Jul 05 15:08:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物 经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学 经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学 经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202623, encodeId=958a12026237d, content=unde r editorial board review 好久了，还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff06473404, createdName=ms7000002025378955, createdTime=Mon Mar 14 23:17:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186804, encodeId=12691186804fc, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：发育生物学 经验分享：Stage Start Date Revision Started 2022-01-20 Waiting for Revision 2021-11-23 Review Complete; E-Mail Notification Sent 2021-11-23 Pending Recommendation 2021-11-16 Under Review 2021-10-26 Under Editor Review 2021-10-25 Under Editorial Board Review 2021-10-21 Quality Control Review Completed 2021-10-21 Quality Control Review Started 2021-10-18 Author Approved Submission 2021-10-18 Preliminary Manuscript Information Submitted 2021-10-18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bb75649951, createdName=ms4000000844349355, createdTime=Fri Jan 21 13:12:55 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841897, encodeId=562184189e40, content=pnas审稿很有意思，先要经过editor board，之后board选择editor，这editor可以是院士，也可以是非院士（guest editor），board和editor都可能拒稿。我的这两个过程耗费时间挺长，比较特殊，原因是editor对文章进行了初步审稿，并提出了详细修改意见和建议。根据意见补充数据修改提交后，editor找了2个审稿人，1个月左右给回复，对创新性、普遍性、数据量、写作等方面给出yes或者no，并提出了具体的意见。补数据修改提交后接收。共耗时8个月。总体感觉：editor水平很高，非常nice，从文章立题到创新性及补充实验等方面提出了很好的建议，极大改进了文章，受益匪浅。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Fri Mar 30 11:35:21 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003853, encodeId=d8131003853df, content=紧张，PNAS效率非常高，官网说送给Reviewers后10天内要求提交报告，因此如果Reviewers不拒审的话，一审时间非常快！ Stage Start Date Pending Recommendation 2021-07-29 Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Fri Jul 30 13:19:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

2022-04-20 Mis 吴

偏重的研究方向：药理学
经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。

226 0

[GetPortalCommentsPageByObjectIdResponse(id=513230, encodeId=4fa5513230d8, content=我的奇葩经历，投cell，没有被送审被拒了。投mol cell，悲剧，还是没送审被拒绝。好吧，投cell res，毕竟是国人期刊，结果你猜啥，天哪，拖了2个月没反应。我真要爆粗口了，于是我果断撤回稿子，怀着忐忑的心情最后试试pnas（再不行就想放弃干脆jbc得了）。意料之外，半月后直接接受，只要改一改格式，真是汗啊。我的经历告诉我，现在的科学，就是金钱和利益和人脉，真正的学术早就不存在了，以后绝对不走科研道路！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.168.51.50, createdTime=Sun Jul 05 15:08:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物 经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学 经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学 经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202623, encodeId=958a12026237d, content=unde r editorial board review 好久了，还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff06473404, createdName=ms7000002025378955, createdTime=Mon Mar 14 23:17:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186804, encodeId=12691186804fc, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：发育生物学 经验分享：Stage Start Date Revision Started 2022-01-20 Waiting for Revision 2021-11-23 Review Complete; E-Mail Notification Sent 2021-11-23 Pending Recommendation 2021-11-16 Under Review 2021-10-26 Under Editor Review 2021-10-25 Under Editorial Board Review 2021-10-21 Quality Control Review Completed 2021-10-21 Quality Control Review Started 2021-10-18 Author Approved Submission 2021-10-18 Preliminary Manuscript Information Submitted 2021-10-18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bb75649951, createdName=ms4000000844349355, createdTime=Fri Jan 21 13:12:55 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841897, encodeId=562184189e40, content=pnas审稿很有意思，先要经过editor board，之后board选择editor，这editor可以是院士，也可以是非院士（guest editor），board和editor都可能拒稿。我的这两个过程耗费时间挺长，比较特殊，原因是editor对文章进行了初步审稿，并提出了详细修改意见和建议。根据意见补充数据修改提交后，editor找了2个审稿人，1个月左右给回复，对创新性、普遍性、数据量、写作等方面给出yes或者no，并提出了具体的意见。补数据修改提交后接收。共耗时8个月。总体感觉：editor水平很高，非常nice，从文章立题到创新性及补充实验等方面提出了很好的建议，极大改进了文章，受益匪浅。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Fri Mar 30 11:35:21 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003853, encodeId=d8131003853df, content=紧张，PNAS效率非常高，官网说送给Reviewers后10天内要求提交报告，因此如果Reviewers不拒审的话，一审时间非常快！ Stage Start Date Pending Recommendation 2021-07-29 Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Fri Jul 30 13:19:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

2022-04-14 ms7000000308199462

偏重的研究方向：生物学
经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前

145 0

[GetPortalCommentsPageByObjectIdResponse(id=513230, encodeId=4fa5513230d8, content=我的奇葩经历，投cell，没有被送审被拒了。投mol cell，悲剧，还是没送审被拒绝。好吧，投cell res，毕竟是国人期刊，结果你猜啥，天哪，拖了2个月没反应。我真要爆粗口了，于是我果断撤回稿子，怀着忐忑的心情最后试试pnas（再不行就想放弃干脆jbc得了）。意料之外，半月后直接接受，只要改一改格式，真是汗啊。我的经历告诉我，现在的科学，就是金钱和利益和人脉，真正的学术早就不存在了，以后绝对不走科研道路！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.168.51.50, createdTime=Sun Jul 05 15:08:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物 经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学 经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学 经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202623, encodeId=958a12026237d, content=unde r editorial board review 好久了，还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff06473404, createdName=ms7000002025378955, createdTime=Mon Mar 14 23:17:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186804, encodeId=12691186804fc, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：发育生物学 经验分享：Stage Start Date Revision Started 2022-01-20 Waiting for Revision 2021-11-23 Review Complete; E-Mail Notification Sent 2021-11-23 Pending Recommendation 2021-11-16 Under Review 2021-10-26 Under Editor Review 2021-10-25 Under Editorial Board Review 2021-10-21 Quality Control Review Completed 2021-10-21 Quality Control Review Started 2021-10-18 Author Approved Submission 2021-10-18 Preliminary Manuscript Information Submitted 2021-10-18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bb75649951, createdName=ms4000000844349355, createdTime=Fri Jan 21 13:12:55 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841897, encodeId=562184189e40, content=pnas审稿很有意思，先要经过editor board，之后board选择editor，这editor可以是院士，也可以是非院士（guest editor），board和editor都可能拒稿。我的这两个过程耗费时间挺长，比较特殊，原因是editor对文章进行了初步审稿，并提出了详细修改意见和建议。根据意见补充数据修改提交后，editor找了2个审稿人，1个月左右给回复，对创新性、普遍性、数据量、写作等方面给出yes或者no，并提出了具体的意见。补数据修改提交后接收。共耗时8个月。总体感觉：editor水平很高，非常nice，从文章立题到创新性及补充实验等方面提出了很好的建议，极大改进了文章，受益匪浅。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Fri Mar 30 11:35:21 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003853, encodeId=d8131003853df, content=紧张，PNAS效率非常高，官网说送给Reviewers后10天内要求提交报告，因此如果Reviewers不拒审的话，一审时间非常快！ Stage Start Date Pending Recommendation 2021-07-29 Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Fri Jul 30 13:19:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

2022-03-14 ms7000002025378955

unde r editorial board review 好久了，还有希望吗

161 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=513230, encodeId=4fa5513230d8, content=我的奇葩经历，投cell，没有被送审被拒了。投mol cell，悲剧，还是没送审被拒绝。好吧，投cell res，毕竟是国人期刊，结果你猜啥，天哪，拖了2个月没反应。我真要爆粗口了，于是我果断撤回稿子，怀着忐忑的心情最后试试pnas（再不行就想放弃干脆jbc得了）。意料之外，半月后直接接受，只要改一改格式，真是汗啊。我的经历告诉我，现在的科学，就是金钱和利益和人脉，真正的学术早就不存在了，以后绝对不走科研道路！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.168.51.50, createdTime=Sun Jul 05 15:08:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物 经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学 经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学 经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202623, encodeId=958a12026237d, content=unde r editorial board review 好久了，还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff06473404, createdName=ms7000002025378955, createdTime=Mon Mar 14 23:17:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186804, encodeId=12691186804fc, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：发育生物学 经验分享：Stage Start Date Revision Started 2022-01-20 Waiting for Revision 2021-11-23 Review Complete; E-Mail Notification Sent 2021-11-23 Pending Recommendation 2021-11-16 Under Review 2021-10-26 Under Editor Review 2021-10-25 Under Editorial Board Review 2021-10-21 Quality Control Review Completed 2021-10-21 Quality Control Review Started 2021-10-18 Author Approved Submission 2021-10-18 Preliminary Manuscript Information Submitted 2021-10-18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bb75649951, createdName=ms4000000844349355, createdTime=Fri Jan 21 13:12:55 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841897, encodeId=562184189e40, content=pnas审稿很有意思，先要经过editor board，之后board选择editor，这editor可以是院士，也可以是非院士（guest editor），board和editor都可能拒稿。我的这两个过程耗费时间挺长，比较特殊，原因是editor对文章进行了初步审稿，并提出了详细修改意见和建议。根据意见补充数据修改提交后，editor找了2个审稿人，1个月左右给回复，对创新性、普遍性、数据量、写作等方面给出yes或者no，并提出了具体的意见。补数据修改提交后接收。共耗时8个月。总体感觉：editor水平很高，非常nice，从文章立题到创新性及补充实验等方面提出了很好的建议，极大改进了文章，受益匪浅。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Fri Mar 30 11:35:21 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003853, encodeId=d8131003853df, content=紧张，PNAS效率非常高，官网说送给Reviewers后10天内要求提交报告，因此如果Reviewers不拒审的话，一审时间非常快！ Stage Start Date Pending Recommendation 2021-07-29 Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Fri Jul 30 13:19:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

2022-03-08 雪花莹

审稿速度:1.0 | 投稿命中率:25.0
经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。

112 0

[GetPortalCommentsPageByObjectIdResponse(id=513230, encodeId=4fa5513230d8, content=我的奇葩经历，投cell，没有被送审被拒了。投mol cell，悲剧，还是没送审被拒绝。好吧，投cell res，毕竟是国人期刊，结果你猜啥，天哪，拖了2个月没反应。我真要爆粗口了，于是我果断撤回稿子，怀着忐忑的心情最后试试pnas（再不行就想放弃干脆jbc得了）。意料之外，半月后直接接受，只要改一改格式，真是汗啊。我的经历告诉我，现在的科学，就是金钱和利益和人脉，真正的学术早就不存在了，以后绝对不走科研道路！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.168.51.50, createdTime=Sun Jul 05 15:08:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物 经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学 经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学 经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202623, encodeId=958a12026237d, content=unde r editorial board review 好久了，还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff06473404, createdName=ms7000002025378955, createdTime=Mon Mar 14 23:17:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186804, encodeId=12691186804fc, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：发育生物学 经验分享：Stage Start Date Revision Started 2022-01-20 Waiting for Revision 2021-11-23 Review Complete; E-Mail Notification Sent 2021-11-23 Pending Recommendation 2021-11-16 Under Review 2021-10-26 Under Editor Review 2021-10-25 Under Editorial Board Review 2021-10-21 Quality Control Review Completed 2021-10-21 Quality Control Review Started 2021-10-18 Author Approved Submission 2021-10-18 Preliminary Manuscript Information Submitted 2021-10-18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bb75649951, createdName=ms4000000844349355, createdTime=Fri Jan 21 13:12:55 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841897, encodeId=562184189e40, content=pnas审稿很有意思，先要经过editor board，之后board选择editor，这editor可以是院士，也可以是非院士（guest editor），board和editor都可能拒稿。我的这两个过程耗费时间挺长，比较特殊，原因是editor对文章进行了初步审稿，并提出了详细修改意见和建议。根据意见补充数据修改提交后，editor找了2个审稿人，1个月左右给回复，对创新性、普遍性、数据量、写作等方面给出yes或者no，并提出了具体的意见。补数据修改提交后接收。共耗时8个月。总体感觉：editor水平很高，非常nice，从文章立题到创新性及补充实验等方面提出了很好的建议，极大改进了文章，受益匪浅。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Fri Mar 30 11:35:21 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003853, encodeId=d8131003853df, content=紧张，PNAS效率非常高，官网说送给Reviewers后10天内要求提交报告，因此如果Reviewers不拒审的话，一审时间非常快！ Stage Start Date Pending Recommendation 2021-07-29 Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Fri Jul 30 13:19:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

2022-01-21 ms4000000844349355

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：发育生物学
经验分享：Stage Start Date
Revision Started 2022-01-20
Waiting for Revision 2021-11-23
Review Complete; E-Mail Notification Sent 2021-11-23
Pending Recommendation 2021-11-16
Under Review 2021-10-26
Under Editor Review 2021-10-25
Under Editorial Board Review 2021-10-21
Quality Control Review Completed 2021-10-21
Quality Control Review Started 2021-10-18
Author Approved Submission 2021-10-18
Preliminary Manuscript Information Submitted 2021-10-18

129 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=513230, encodeId=4fa5513230d8, content=我的奇葩经历，投cell，没有被送审被拒了。投mol cell，悲剧，还是没送审被拒绝。好吧，投cell res，毕竟是国人期刊，结果你猜啥，天哪，拖了2个月没反应。我真要爆粗口了，于是我果断撤回稿子，怀着忐忑的心情最后试试pnas（再不行就想放弃干脆jbc得了）。意料之外，半月后直接接受，只要改一改格式，真是汗啊。我的经历告诉我，现在的科学，就是金钱和利益和人脉，真正的学术早就不存在了，以后绝对不走科研道路！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.168.51.50, createdTime=Sun Jul 05 15:08:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物 经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学 经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学 经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202623, encodeId=958a12026237d, content=unde r editorial board review 好久了，还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff06473404, createdName=ms7000002025378955, createdTime=Mon Mar 14 23:17:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186804, encodeId=12691186804fc, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：发育生物学 经验分享：Stage Start Date Revision Started 2022-01-20 Waiting for Revision 2021-11-23 Review Complete; E-Mail Notification Sent 2021-11-23 Pending Recommendation 2021-11-16 Under Review 2021-10-26 Under Editor Review 2021-10-25 Under Editorial Board Review 2021-10-21 Quality Control Review Completed 2021-10-21 Quality Control Review Started 2021-10-18 Author Approved Submission 2021-10-18 Preliminary Manuscript Information Submitted 2021-10-18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bb75649951, createdName=ms4000000844349355, createdTime=Fri Jan 21 13:12:55 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841897, encodeId=562184189e40, content=pnas审稿很有意思，先要经过editor board，之后board选择editor，这editor可以是院士，也可以是非院士（guest editor），board和editor都可能拒稿。我的这两个过程耗费时间挺长，比较特殊，原因是editor对文章进行了初步审稿，并提出了详细修改意见和建议。根据意见补充数据修改提交后，editor找了2个审稿人，1个月左右给回复，对创新性、普遍性、数据量、写作等方面给出yes或者no，并提出了具体的意见。补数据修改提交后接收。共耗时8个月。总体感觉：editor水平很高，非常nice，从文章立题到创新性及补充实验等方面提出了很好的建议，极大改进了文章，受益匪浅。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Fri Mar 30 11:35:21 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003853, encodeId=d8131003853df, content=紧张，PNAS效率非常高，官网说送给Reviewers后10天内要求提交报告，因此如果Reviewers不拒审的话，一审时间非常快！ Stage Start Date Pending Recommendation 2021-07-29 Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Fri Jul 30 13:19:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

2018-03-30 ms622773450447966

pnas审稿很有意思，先要经过editor board，之后board选择editor，这editor可以是院士，也可以是非院士（guest editor），board和editor都可能拒稿。我的这两个过程耗费时间挺长，比较特殊，原因是editor对文章进行了初步审稿，并提出了详细修改意见和建议。根据意见补充数据修改提交后，editor找了2个审稿人，1个月左右给回复，对创新性、普遍性、数据量、写作等方面给出yes或者no，并提出了具体的意见。补数据修改提交后接收。共耗时8个月。总体感觉：editor水平很高，非常nice，从文章立题到创新性及补充实验等方面提出了很好的建议，极大改进了文章，受益匪浅。

156 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=513230, encodeId=4fa5513230d8, content=我的奇葩经历，投cell，没有被送审被拒了。投mol cell，悲剧，还是没送审被拒绝。好吧，投cell res，毕竟是国人期刊，结果你猜啥，天哪，拖了2个月没反应。我真要爆粗口了，于是我果断撤回稿子，怀着忐忑的心情最后试试pnas（再不行就想放弃干脆jbc得了）。意料之外，半月后直接接受，只要改一改格式，真是汗啊。我的经历告诉我，现在的科学，就是金钱和利益和人脉，真正的学术早就不存在了，以后绝对不走科研道路！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1198, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=60.168.51.50, createdTime=Sun Jul 05 15:08:00 CST 2015, time=2015-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225526, encodeId=f337122552659, content=收到 receipt邮件，we are currently experiencing delays due to pandemic and high volume of submissions..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=237, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a82b5450835, createdName=osmataku, createdTime=Thu Jun 09 21:45:13 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218376, encodeId=861a12183e6cb, content=偏重的研究方向：微生物 经验分享：iii, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88f8155447, createdName=ms1000000471957018, createdTime=Tue May 10 09:43:24 CST 2022, time=2022-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212897, encodeId=c5ee121289e7a, content=偏重的研究方向：药理学 经验分享：有没有转投的朋友，你们现在都是什么情况？我的已经超过2个月了，意见还没回来。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9b85535861, createdName=Mis 吴, createdTime=Wed Apr 20 16:49:54 CST 2022, time=2022-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211126, encodeId=105c12111265c, content=偏重的研究方向：生物学 经验分享：请问有没有人申诉过？为什么我申诉完了文章接又回到了quality control了？没有任何邮件提前, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0e5b5549664, createdName=ms7000000308199462, createdTime=Thu Apr 14 13:24:29 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202623, encodeId=958a12026237d, content=unde r editorial board review 好久了，还有希望吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cff06473404, createdName=ms7000002025378955, createdTime=Mon Mar 14 23:17:10 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200700, encodeId=b9991200e0018, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：审稿效率很高，从投稿到一次大修、一次小修到发表，用了将近6个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/19/33743bc2d24e69358e6f25bd90b7d57b.jpg, createdBy=82831648405, createdName=雪花莹, createdTime=Tue Mar 08 22:09:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186804, encodeId=12691186804fc, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：发育生物学 经验分享：Stage Start Date Revision Started 2022-01-20 Waiting for Revision 2021-11-23 Review Complete; E-Mail Notification Sent 2021-11-23 Pending Recommendation 2021-11-16 Under Review 2021-10-26 Under Editor Review 2021-10-25 Under Editorial Board Review 2021-10-21 Quality Control Review Completed 2021-10-21 Quality Control Review Started 2021-10-18 Author Approved Submission 2021-10-18 Preliminary Manuscript Information Submitted 2021-10-18, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bb75649951, createdName=ms4000000844349355, createdTime=Fri Jan 21 13:12:55 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=841897, encodeId=562184189e40, content=pnas审稿很有意思，先要经过editor board，之后board选择editor，这editor可以是院士，也可以是非院士（guest editor），board和editor都可能拒稿。我的这两个过程耗费时间挺长，比较特殊，原因是editor对文章进行了初步审稿，并提出了详细修改意见和建议。根据意见补充数据修改提交后，editor找了2个审稿人，1个月左右给回复，对创新性、普遍性、数据量、写作等方面给出yes或者no，并提出了具体的意见。补数据修改提交后接收。共耗时8个月。总体感觉：editor水平很高，非常nice，从文章立题到创新性及补充实验等方面提出了很好的建议，极大改进了文章，受益匪浅。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=156, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=573a5414124, createdName=ms622773450447966, createdTime=Fri Mar 30 11:35:21 CST 2018, time=2018-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003853, encodeId=d8131003853df, content=紧张，PNAS效率非常高，官网说送给Reviewers后10天内要求提交报告，因此如果Reviewers不拒审的话，一审时间非常快！ Stage Start Date Pending Recommendation 2021-07-29 Under Review 2021-07-19 Under Editor Review 2021-07-18 Under Editorial Board Review 2021-07-14 Quality Control Review Completed 2021-07-14 Quality Control Issue Identified 2021-07-13 Quality Control Review Started 2021-07-11 Author Approved Submission 2021-07-11 Preliminary Manuscript Information Submitted 2021-07-11, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7e0d5546701, createdName=ms5000000115506285, createdTime=Fri Jul 30 13:19:41 CST 2021, time=2021-07-30, status=1, ipAttribution=)]

2021-07-30 ms5000000115506285

紧张，PNAS效率非常高，官网说送给Reviewers后10天内要求提交报告，因此如果Reviewers不拒审的话，一审时间非常快！
Stage Start Date
Pending Recommendation 2021-07-29
Under Review 2021-07-19
Under Editor Review 2021-07-18
Under Editorial Board Review 2021-07-14
Quality Control Review Completed 2021-07-14
Quality Control Issue Identified 2021-07-13
Quality Control Review Started 2021-07-11
Author Approved Submission 2021-07-11
Preliminary Manuscript Information Submitted 2021-07-11

187 12

展开12条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务